Martin Muenchbach
Managing Partner at Pureos Bioventures
Switzerland
Martin Muenchbach, Managing Partner at Pureos Bioventures is an active investor based in Switzerland. This profile covers what Martin Muenchbach backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCPE
- Stages
- SeedSeries ASeries BLate Stage Venture
- Invests in
- Biotech & PharmaMedTech & Medical Devices
- Location
- Switzerland
- Typical check
- $2M
- Past investments
- 13
Notable investments
AM Pharma
Vico Therapeutics
Citryll
NovaGo Therapeutics
Corlieve TherapeuticsAriceum TherapeuticsRiver Renal Inc
Alentis Therapeutics
EyevensysCASCINATION
Araris Biotech
Lava TherapeuticsHow to reach Martin Muenchbach
Angels and operators like Martin Muenchbach reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Martin Muenchbach
Frequently Asked Questions
What does Martin Muenchbach invest in?
Martin Muenchbach invests in Biotech & Pharma and MedTech & Medical Devices, typically at Seed, Series A, Series B and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Martin Muenchbach invest at?
Martin Muenchbach typically invests at Seed, Series A, Series B and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Martin Muenchbach's typical check size?
Martin Muenchbach typically writes checks around $2M. Use it as a signal for whether your raise fits their stage.
How do I contact Martin Muenchbach?
Unlock Martin Muenchbach's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.